2009
DOI: 10.1016/j.imlet.2009.08.008
|View full text |Cite
|
Sign up to set email alerts
|

CD28−CD8+ T cells do not contain unique clonotypes and are therefore dispensable

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
28
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 21 publications
(28 citation statements)
references
References 63 publications
(85 reference statements)
0
28
0
Order By: Relevance
“…To analyze the clonal composition of BM derived T cells of a certain specificity, we stimulated BMMC as well as PBMC with the peptide CMV NLV for two weeks following a previously published protocol [9,10]. It was of interest that the starting population from the BM contained more CMV NLV specific cells than the corresponding population from the PB (12.5% ± 3.2, n = 5: BM versus 5.0% ± 3.6; n = 5: PB; p < 0.01).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…To analyze the clonal composition of BM derived T cells of a certain specificity, we stimulated BMMC as well as PBMC with the peptide CMV NLV for two weeks following a previously published protocol [9,10]. It was of interest that the starting population from the BM contained more CMV NLV specific cells than the corresponding population from the PB (12.5% ± 3.2, n = 5: BM versus 5.0% ± 3.6; n = 5: PB; p < 0.01).…”
Section: Resultsmentioning
confidence: 99%
“…During this time they were restimulated with IL-2 (20 ng/ml) (Novartis) every three days and with peptide once on day 7. After 14 days CMV NLV specific CD8 + T cells were purified using MACS technology, as previously described [10]. Briefly, CMV specific CD8 + T cells were positively selected using APC-coupled CMV NLV pentamers, followed by the addition of anti-APC-antibodies coupled with magnetic beads (all (BD Pharmingen) and a LS column (Miltenyi Biotec).…”
Section: Methodsmentioning
confidence: 99%
“…49-51 Finally, there exists the possibility that CD28 − T cells may just be residual cells from prior antigen exposures that do not offer any unique clonotypes, and thus are largely dispensable. 14 In any event, achieving a higher resolution of understanding in this interplay of costimulation and coinhibitory pathways in the context of CD28 loss will play an immense role in therapeutic development for many human diseases.…”
Section: Discussionmentioning
confidence: 99%
“…14 This consequently leads to an immune system compromised by limited antigenic diversity. Furthermore, age-related thymic involution and its related reduced output in naïve CD28+ T cells may also contribute to an aged and weakened immune phenotype.…”
Section: Clinical Relevance Of Cd28− T Cellsmentioning
confidence: 99%
“…Recent studies have shown that the same clonotypes occur in both, early memory CD8 + T cells and highly differentiated CD8 + CD28 -T cells, indicating no loss of unique T cell specificities when depleting CD8 + CD28 -T cells [137,138]. For example, the depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory systemic lupus erythematosus induced long-term remission through de novo generation of a juvenile and tolerant immune system [139].…”
Section: Strategiesmentioning
confidence: 99%